DENVER, April 25 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R) Inc., (OTC:GLOB) (BULLETIN BOARD: GLOB) announced today that St. John's Medical Center has purchased its SafeTrace Tx(R)* advanced transfusion management system. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) St. John's Medical Center will be moving to an automated blood bank with Wyndgate's SafeTrace Tx solution. The installation of this system will allow the blood bank to streamline information from the hospital's laboratory and other electronic record systems as well as input and track its own data. Blood bank employees will be able to track specimens and test results more easily and quickly with the new system. Blood Bank Supervisor Judy Lewis, MT, SBB(ASCP), voiced her enthusiasm about the system saying, "We are very excited to have SafeTrace Tx in our laboratory. We have been operating with a manual paper system, which was cumbersome and time-consuming. SafeTrace Tx will improve our record keeping with less time involved. The Patient-At-A-Glance Bar(TM) is a great feature for patient history review and current specimen expiration time. We believe SafeTrace Tx has many safety features that will help St. John's." The ability of SafeTrace Tx to interface with the other computerized systems at St. John's was a key element in its purchase because it ensures that the medical center may continue building its network and improving access to information. "Another consideration in St. John's choosing SafeTrace Tx is Wyndgate's partnership with our current HIS vendor. This partnership is important to our medical center for future integration," stated Redeem Sumicad, MBA, MLT(ASCP), Administrative Director of the Laboratory at St. John's. "More and more blood banks are choosing to go to electronic software systems to take advantage of faster, easier, and more thorough specimen management," commented Wm. Scott Dustin, Vice President of Sales and Marketing. "We are pleased to be able to help St. John's Medical Center realize these benefits and maintain their high standards for safety. We look forward to working with St. John's and their new system." About St. John's Medical Center St. John's Medical Center is a fully-accredited medical center and long-term care facility in Jackson Hole, Wyoming. The medical center serves the needs of Teton and surrounding counties. St. John's Medical Center boasts a state-of-the-art Clinical Laboratory and Diagnostics Imaging facilities. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or Investor Relations, Paul Short, President of Investment Strategies, LLC, +1-304-523-3252, for Global Med Technologies Inc. Web site: http://www.globalmedtech.com/ http://www.wyndgate.com/

Copyright